Eagle Pharmaceuticals Inc (NASDAQ:EGRX)

41.56
Delayed Data
As of Apr 09
 +0.36 / +0.87%
Today’s Change
36.48
Today|||52-Week Range
56.16
-10.76%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Tarriff Scott L
Chief Executive Officer
Sale4/01/202116,278$41.87$681.6K-0.74%
Tarriff Scott L
Chief Executive Officer
Buy4/01/202131,201$8.78$273.9K-0.74%
Tarriff Scott L
Chief Executive Officer
Sale1/23/20214,631$47.70$220.9K-14.91%
Pernock David M
President & Chief Operating Officer
Sale1/05/20212,088$50.02$104.4K-16.91%
Pernock David M
President & Chief Operating Officer
Sale1/23/20211,892$47.70$90.2K-14.91%
Pernock David M
President & Chief Operating Officer
Sale1/07/2021906$50.97$46.2K-18.46%
Cahill Brian /eagle/
Chief Financial Officer
Sale1/05/2021746$50.02$37.3K-16.91%
Cahill Brian /eagle/
Chief Financial Officer
Sale1/29/2021637$46.67$29.7K-10.95%
Cahill Brian /eagle/
Chief Financial Officer
Sale1/07/2021237$50.97$12.1K-18.46%
Cahill Brian /eagle/
Chief Financial Officer
Gift12/18/20205,000$0.00$0.00-13.58%
Page of 2